中西医联合治疗弱精不育患者的临床研究

Clinical Study on Combined Treatment of Traditional Chinese Medicine and Western Medicine for Patients with Asthenospermia

目的:研究中西医治疗弱精症对男性精子生化指标的作用,为治疗弱精症患者带来帮助。方法:基于中医学的传统理论,选择2015年6月-2016年2月来本院生殖科就诊的男性少弱精导致不育患者80例为研究对象,以传统中药配方药物联合西医为治疗手段,以测定精液酸性磷酸酶(ACP)、精子顶体酶、α-葡萄糖苷酶、精子活力(A+B级)等指标来观测其临床疗效,持续跟踪一年;用以评价中西医联合治疗弱精症的有效性。结果:接受治疗的80例弱精患者中,ACP、精子顶体酶、α-葡萄糖苷酶、(A+B级)精子比率分别由治疗前的(41.5±7.5)IU/L、(10.7±3.3)U/L、(32.5±7.5)U/L、(5.5±2.4)%,1年后分别上升至(136.7±15.5)IU/L、(47.3±11.5)U/L、(97.4±25.6)U/L、(21.1±5.1)%,差异均有统计学意义(P<0.05)。结论:中西医联合治疗弱精症疗效确切,对患者精子生化指标改善明显。

Objective： To study the effect of traditional Chinese Medicine on the treatment of weak spermatozoa.Method： From June 2015 to February 2017, 80 weak patients clinical diagnosis in our hospital were selected based on the traditional theory of traditional Chinese medicine, they were treated with traditional Chinese medicine prescription drugs combined with western medicine.Semen to acid phosphatase （ ACP ）, sperm acrosin, α -glucose Glycosidase, sperm motility （ A＋B ） ratio and other indicators were observed and continuous tracked 1 year to evaluate the clinical efficacy of traditional Chinese and western medicine for asthenospermia. Result： The levels of ACP, sperm acrosin, α-glucosidase and sperm motility （ A＋B ） ratio before treatment were （ 41.5 ± 7.5 ） IU/L, （ 10.7 ± 3.3 ） U/L, （ 32.5 ± 7.5 ） U/L, （ 5.5 ± 2.4 ） % respectively, and were （ 136.7 ± 15.5 ）IU/L, （47.3 ± 11.5 ） U/L, （ 97.4 ± 25.6 ） U/L, （ 21.1 ± 5.1 ） % after 1 year, the differences were statistically significant （ P〈0.05 ） .Conehlsion： Traditional Chinese medicine combined with western medicine in the treatment for asthenospermia is effective, and has obvious improvement on the biochemical indexes of the sperm quality.